Matches in Wikidata for { <http://www.wikidata.org/entity/Q91622917> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91622917 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91622917 description "scientific article published on 13 February 2019" @default.
- Q91622917 description "wetenschappelijk artikel" @default.
- Q91622917 description "наукова стаття, опублікована 13 лютого 2019" @default.
- Q91622917 name "MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats" @default.
- Q91622917 name "MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats" @default.
- Q91622917 type Item @default.
- Q91622917 label "MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats" @default.
- Q91622917 label "MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats" @default.
- Q91622917 prefLabel "MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats" @default.
- Q91622917 prefLabel "MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats" @default.
- Q91622917 P1104 Q91622917-A542318A-5C6B-4146-A6C6-056D22E98D40 @default.
- Q91622917 P1433 Q91622917-DF5E198D-281F-4CCA-A259-3529BAD26DDB @default.
- Q91622917 P1476 Q91622917-4863E080-D6B2-4406-B22B-5F3433BB5AD4 @default.
- Q91622917 P2093 Q91622917-410F188B-B76E-4A27-9740-921AD7E57EDE @default.
- Q91622917 P304 Q91622917-7CB82453-B31A-48D6-A4CF-27F163DCA5C1 @default.
- Q91622917 P31 Q91622917-D2E8A0F6-0CF5-4C9F-9A64-46881FD73DEB @default.
- Q91622917 P356 Q91622917-B53BDA43-7893-4744-ABA6-4D5036BB174F @default.
- Q91622917 P478 Q91622917-52F9BBBE-63F3-4F8F-8F6E-516AE88B200C @default.
- Q91622917 P50 Q91622917-41246ED2-B919-4743-9726-F9428F935CD2 @default.
- Q91622917 P50 Q91622917-6BB85ECA-B353-4B77-8958-C2378283BC7D @default.
- Q91622917 P50 Q91622917-E068BA64-B300-4B0C-8593-56767F1C40D9 @default.
- Q91622917 P50 Q91622917-F75F7ADB-FFFA-4518-BABF-081DAB52ABEB @default.
- Q91622917 P577 Q91622917-9D5E7145-026A-40EE-88F8-06A240B7BF7E @default.
- Q91622917 P698 Q91622917-B0324739-84D9-4378-B15A-C43EF30DF945 @default.
- Q91622917 P356 J.NEUROPHARM.2019.02.010 @default.
- Q91622917 P698 30768946 @default.
- Q91622917 P1104 "+12" @default.
- Q91622917 P1433 Q15332439 @default.
- Q91622917 P1476 "MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats" @default.
- Q91622917 P2093 "Gavril W Pasternak" @default.
- Q91622917 P304 "217-228" @default.
- Q91622917 P31 Q13442814 @default.
- Q91622917 P356 "10.1016/J.NEUROPHARM.2019.02.010" @default.
- Q91622917 P478 "150" @default.
- Q91622917 P50 Q117304205 @default.
- Q91622917 P50 Q40465205 @default.
- Q91622917 P50 Q95336004 @default.
- Q91622917 P50 Q95336022 @default.
- Q91622917 P577 "2019-02-13T00:00:00Z" @default.
- Q91622917 P698 "30768946" @default.